APA (7th ed.) Citation

Lei, J., Zhang, J., You, C., Fu, W., Liu, M., & Li, N. First-line treatment with zolbetuximab plus CAPOX for ClDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: A cost-effectiveness analysis. SAGE Publishing.

Chicago Style (17th ed.) Citation

Lei, Jianying, Jiahao Zhang, Caicong You, Wu Fu, Maobai Liu, and Na Li. First-line Treatment with Zolbetuximab Plus CAPOX for ClDN18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma: A Cost-effectiveness Analysis. SAGE Publishing.

MLA (9th ed.) Citation

Lei, Jianying, et al. First-line Treatment with Zolbetuximab Plus CAPOX for ClDN18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma: A Cost-effectiveness Analysis. SAGE Publishing.